Prosecution Insights
Last updated: April 19, 2026
Application No. 18/478,518

ORGANIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE

Non-Final OA §102§103
Filed
Sep 29, 2023
Examiner
HOU, FRANK S
Art Unit
1692
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Samsung Display Co., Ltd.
OA Round
1 (Non-Final)
71%
Grant Probability
Favorable
1-2
OA Rounds
3y 2m
To Grant
99%
With Interview

Examiner Intelligence

Grants 71% — above average
71%
Career Allow Rate
82 granted / 115 resolved
+11.3% vs TC avg
Strong +32% interview lift
Without
With
+31.8%
Interview Lift
resolved cases with interview
Typical timeline
3y 2m
Avg Prosecution
49 currently pending
Career history
164
Total Applications
across all art units

Statute-Specific Performance

§101
0.9%
-39.1% vs TC avg
§103
33.7%
-6.3% vs TC avg
§102
24.2%
-15.8% vs TC avg
§112
22.3%
-17.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 115 resolved cases

Office Action

§102 §103
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . DETAILED ACTION Claims 1-20 of H. Kim, et al., US 18/478,518 (09/29/2023) are pending. Claims 1-6 are withdrawn as directed to non-elected Group. Claims 7-20 are under examination on merits. Claims 7-11 and 13-20 are rejected, claim 12 is objected to. Election/Restrictions Pursuant to the restriction requirement, Applicant elected Group II, without traverse, in the reply filed on 01/20/2026. Claims 1-6 drawn to Group (I) are withdrawn from consideration pursuant to 37 CFR 1.142(b). The restriction requirement is made as FINAL. Claim Objections Claim 12 is objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale or otherwise available to the public before the effective filing date of the claimed invention. (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claims 7-11, 13-16 and 18-20 are rejected under 35 U.S.C. 102(a)(1) as being anticipated by J. S. Hong, et al, KR20170090942A (2017)(“Hong”). Hong is published in Korean, a copy of machine translation is attached as the second part of the reference, which results in the total page of the full reference is 49, the format for citation of the reference is xx /49. Hong teaches a compound 23 that has a chemical structure as indicated below. PNG media_image1.png 310 279 media_image1.png Greyscale Hong at page 27/49, Synthetic example 7: Synthesis of Compound 23. The compound 23 has the same chemical structure as that of the claimed species 41 in the instant claim 20, which maps the Formula 1 in claims 7-11, 13-16 and 18-19 as: Each of a1 and a2 is 0, each of L1 and L2 is a bond; Each of R1 and R2 is phenyl, a3 is 1, L3 is phenyl; R39 is phenyl; Each of X31,X33-X35 and X37-X38 is CH and Each X32 and X36 is N. Which meets each and every limitation of claims 7-11, 13-16 and 18-20, therefore, claims 7-11, 13-16 and 18-20 are anticipated. PNG media_image2.png 470 754 media_image2.png Greyscale Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. Claims 7-11 and 13-20 are rejected under 35 U.S.C. 103 as being unpatentable over S. Y. Lee, et al, WO2011055912A1(2011)(“Lee”) in view of J. S. Hong, et al, KR20170090942A (2017)(“Hong”). S. Y. Lee, et al, WO 2011055912 A1 (2011)(“Lee”) Lee teaches an organic electroluminescent compound represented by Chemical Formula 1 that can be used as a host material for an OLED. PNG media_image3.png 321 364 media_image3.png Greyscale Lee at page 2-3, [8]-[12], emphasis added. Lee teaches example compounds of the Chemical Formula 1, such as compounds 19, 20, 28 and 31 with structures as indicated below. Lee at page 7, [38] for compound 19-20, [40] for compound 28 and [41] for compound 31. PNG media_image4.png 1644 1599 media_image4.png Greyscale Lee compounds compound 28 maps the Formula 1 in the instant claim 7-as: Each of a1 and a2 is 0, each of L1 and L2 is a bond; Each of R1 and R2 is phenyl, a3 is 1, L3 is phenyl; R39 is phenyl; b3 is 1, R40 is phenyl; Each of X31-X32, X34 and X35-X36, X38 is CH; X33 is CR33 wherein, R33 is phenyl; and X37 is CR37 wherein, R37 is phenyl. Difference between Lee and the instant Claim 7 Lee compound 28 differs from the instant claim 7 only in that there is no least one of X31-X38 is N as claimed by the instant claim 7. PNG media_image5.png 919 878 media_image5.png Greyscale J. S. Hong, et al, KR20170090942A (2017)(“Hong”) Hong is published in Korean, a copy of machine translation is attached as the second part of the reference, which results in the total page of the full reference is 49, the format for citation of the reference is xx /49. Hong teaches an organic compound capable of implementing high efficiency and long lasting organic optoelectronic devices and the organic compound represented by the following formula (1). Hong at page 33/49, line 19-24 and page 3/49 for the structure of formula (1), emphasis added. Hong teaches that the organic compound formula (1) may be represented by the following formula (1a). PNG media_image6.png 140 225 media_image6.png Greyscale Hong at page 36/49, paragraph 11 and page 4/49 for the structure of formula (1a). Hong teaches example compounds such as compound 3, 27, 31 with structures as indicated below. PNG media_image7.png 818 2422 media_image7.png Greyscale Hong at page 17/49, [0086] for compound 3, at page 18/49, [0092] for compound 27 and [0093] for compound 31. After comparing the structures of Lee compounds 19, 20, 31 with the Hong compounds 31, 27 and 3 respectively, one ordinary skill would be appraised that the moiety of PNG media_image8.png 214 307 media_image8.png Greyscale in Lee compound can be replace by PNG media_image9.png 214 336 media_image9.png Greyscale as indicated below. PNG media_image10.png 2155 1924 media_image10.png Greyscale Hong also teaches an OLED made with the example compound 3 as a host compound, which exhibits improved characteristics in terms of driving voltage, luminous efficiency and / or power efficiency. Hong at page 48/49-49/49, Example 2 to 12. Obviousness Rationales of the Claims 7-11 and 13-20 Obviousness of a claimed compound can also be supported where there is motivation to substitute particular chemical moieties in a prior art compound for others so as to arrive at a claimed compound. MPEP § 2143(I)(B). For example, in the pharmaceutical arts, the rational is stated as motivation to select a known compound and also motivation to structurally modify the selected compound in a particular way to achieve a claimed compound. MPEP § 2143(I)(B) (see for example, MPEP § 2143(I)(B) Example 9, citing Eisai Co. Ltd. v. Dr. Reddy’s Labs., Ltd., 533 F.3d 1353, 87 USPQ2d 1452 (Fed. Cir. 2008). One of ordinary skill is motivated to select Lee’s compound 28 for further investigation because Lee discloses it as an example of the Chemical Formula 1 and it can be used as host material for an OLED. Having selected the Lee compound 28, one of ordinary skill is motivated to substitute the moiety of PNG media_image8.png 214 307 media_image8.png Greyscale in the Lee compound with the moiety of PNG media_image9.png 214 336 media_image9.png Greyscale in Hong compounds as follows, thereby arriving at a compound falling within the chemical genera of instant claims 7-11, 13-19, therefore, claim 7-11 and 13-19 are obvious. PNG media_image11.png 875 2278 media_image11.png Greyscale One of ordinary skill has a motivation to do so with a reasonable expectation of success because Hong teaches that the moiety of PNG media_image8.png 214 307 media_image8.png Greyscale in Lee compound can be replace by PNG media_image9.png 214 336 media_image9.png Greyscale and the modified compound capable of implementing high efficiency and long lasting organic optoelectronic devices when used as a host compound. Subject Matter Free of the Art Claim 12 is free of the art recorded. The closest prior art of record J. S. Hong, et al, KR20170090942A (2017)(“Hong”). J. S. Hong, et al, KR20170090942A (2017)(“Hong”) As detail mentioned in the 102 rejection above that Hong teaches the compound 23 which meets each and every limitation of claim 7. Different between Hong and the instant claim 12 Hong differs from the instant claim 12 in that none of R1 and R2 in the Hong compound 23 or other compounds taught by Hong is not a carbazolyl group. Claim 12 is not Obvious Claim 12 is not obvious because neither Hong or Hong in view a second art to motivate one ordinary skill to modify the Hong prior art compound by replacing the phenyl group(s) R1/R2 with a carbazolyl group thus arrive at the claimed compound. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to FRANK S. HOU whose telephone number is (571)272-1802. The examiner can normally be reached 6:30 am-2:30 pm Eastern on Monday to Friday. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Scarlett Goon can be reached at (571)2705241. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /FRANK S. HOU/Examiner, Art Unit 1692 /ALEXANDER R PAGANO/Primary Examiner, Art Unit 1692
Read full office action

Prosecution Timeline

Sep 29, 2023
Application Filed
Mar 03, 2026
Non-Final Rejection — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12583876
BRANCHED ORGANOSILICON COMPOUND, METHOD OF PREPARING SAME, AND RELATED COMPOSITIONS
2y 5m to grant Granted Mar 24, 2026
Patent 12577194
METHOD FOR THE HYDROGENATION OF AROMATIC NITRO COMPOUNDS
2y 5m to grant Granted Mar 17, 2026
Patent 12577265
ISOCYANATE GROUP-CONTAINING ORGANOSILICON COMPOUND AND METHOD FOR PRODUCING ISOCYANATE GROUP-CONTAINING ORGANOSILICON COMPOUND
2y 5m to grant Granted Mar 17, 2026
Patent 12570676
MULTIFUNCTIONALIZED SILICON NANOPARTICLES, PROCESS FOR THEIR PREPARATION AND USES THEREOF IN ELECTROCHEMILUMINESCENCE BASED DETECTION METHODS
2y 5m to grant Granted Mar 10, 2026
Patent 12570601
PROCESS FOR PREPARING (R)-4-AMINOINDANE AND CORRESPONDING AMIDES
2y 5m to grant Granted Mar 10, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
71%
Grant Probability
99%
With Interview (+31.8%)
3y 2m
Median Time to Grant
Low
PTA Risk
Based on 115 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month